Gene Activity List

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 13 of 1714:
3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23
Gene Compound Assay Inh Ic50 Ki View
sodium channel, voltage-gated, type III, beta BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, voltage-gated, type XI, alpha BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, voltage-gated, type I, beta BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, voltage-gated, type 10, alpha polypeptide BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, voltage-gated, type IV, alpha polypeptide BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, voltage-gated, type V, alpha polypeptide BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, voltage-gated, type II, beta BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, nonvoltage-gated 1 alpha BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, nonvoltage-gated 1 gamma BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, nonvoltage-gated 1 beta BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, voltage-gated, type XI, alpha BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, nonvoltage-gated 1, gamma BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, nonvoltage-gated 1, delta BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, nonvoltage-gated 1 alpha BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, voltage-gated, type X, alpha BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, voltage-gated, type IX, alpha BENZETHONIUM CHLORIDE Sodium Channel, Site 2 100% .254uM .232uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, nonvoltage-gated 1 alpha ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, voltage-gated, type X, alpha ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, voltage-gated, type IX, alpha ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, voltage gated, type VIII, alpha ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, voltage-gated, type VII, alpha ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, voltage-gated, type IV, beta ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, voltage-gated, type IV, alpha ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, voltage-gated, type III, alpha ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, voltage-gated, type II, beta ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, voltage-gated, type II, alpha 2 ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, voltage-gated, type I, beta ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, voltage-gated, type I, alpha ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
histamine receptor H 1 ASTEMIZOLE Histamine H1, Central 100% .014uM .001611uM View
tachykinin receptor 2 ASTEMIZOLE Tachykinin NK2 100% 2.986uM .995uM View
5-hydroxytryptamine (serotonin) receptor 3a ASTEMIZOLE Serotonin 5-HT3 100% .426uM .096uM View
5-hydroxytryptamine (serotonin) receptor 3b ASTEMIZOLE Serotonin 5-HT3 100% .426uM .096uM View
calcium channel, voltage-dependent, gamma subunit 8 ASTEMIZOLE Calcium Channel Type L, Benzothiazepine 100% 1.102uM .98uM View
calcium channel, voltage-dependent, gamma subunit 7 ASTEMIZOLE Calcium Channel Type L, Benzothiazepine 100% 1.102uM .98uM View
calcium channel, voltage-dependent, gamma subunit 6 ASTEMIZOLE Calcium Channel Type L, Benzothiazepine 100% 1.102uM .98uM View
calcium channel, voltage-dependent, gamma subunit 5 ASTEMIZOLE Calcium Channel Type L, Benzothiazepine 100% 1.102uM .98uM View
calcium channel, voltage-dependent, gamma subunit 4 ASTEMIZOLE Calcium Channel Type L, Benzothiazepine 100% 1.102uM .98uM View
calcium channel, voltage-dependent, gamma subunit 3 ASTEMIZOLE Calcium Channel Type L, Benzothiazepine 100% 1.102uM .98uM View
calcium channel, voltage-dependent, gamma subunit 2 ASTEMIZOLE Calcium Channel Type L, Benzothiazepine 100% 1.102uM .98uM View
calcium channel, voltage-dependent, gamma subunit 1 ASTEMIZOLE Calcium Channel Type L, Benzothiazepine 100% 1.102uM .98uM View
calcium channel, voltage-dependent, beta 4 subunit ASTEMIZOLE Calcium Channel Type L, Benzothiazepine 100% 1.102uM .98uM View
calcium channel, voltage-dependent, beta 3 subunit ASTEMIZOLE Calcium Channel Type L, Benzothiazepine 100% 1.102uM .98uM View
calcium channel, voltage-dependent, beta 2 subunit ASTEMIZOLE Calcium Channel Type L, Benzothiazepine 100% 1.102uM .98uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit ASTEMIZOLE Calcium Channel Type L, Benzothiazepine 100% 1.102uM .98uM View
calcium channel, voltage-dependent, alpha 1F subunit ASTEMIZOLE Calcium Channel Type L, Benzothiazepine 100% 1.102uM .98uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit ASTEMIZOLE Calcium Channel Type L, Benzothiazepine 100% 1.102uM .98uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit ASTEMIZOLE Calcium Channel Type L, Benzothiazepine 100% 1.102uM .98uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit ASTEMIZOLE Calcium Channel Type L, Benzothiazepine 100% 1.102uM .98uM View
calcium channel, voltage-dependent, beta 1 subunit ASTEMIZOLE Calcium Channel Type L, Benzothiazepine 100% 1.102uM .98uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit ASTEMIZOLE Calcium Channel Type L, Benzothiazepine 100% 1.102uM .98uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit ASTEMIZOLE Calcium Channel Type L, Benzothiazepine 100% 1.102uM .98uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 ASTEMIZOLE Calcium Channel Type L, Benzothiazepine 100% 1.102uM .98uM View
calcium channel, voltage-dependent, gamma subunit 8 ASTEMIZOLE Calcium Channel Type L, Dihydropyridine 100% 1.617uM 1.04uM View
calcium channel, voltage-dependent, gamma subunit 7 ASTEMIZOLE Calcium Channel Type L, Dihydropyridine 100% 1.617uM 1.04uM View
calcium channel, voltage-dependent, gamma subunit 6 ASTEMIZOLE Calcium Channel Type L, Dihydropyridine 100% 1.617uM 1.04uM View
calcium channel, voltage-dependent, gamma subunit 5 ASTEMIZOLE Calcium Channel Type L, Dihydropyridine 100% 1.617uM 1.04uM View
calcium channel, voltage-dependent, gamma subunit 4 ASTEMIZOLE Calcium Channel Type L, Dihydropyridine 100% 1.617uM 1.04uM View
calcium channel, voltage-dependent, gamma subunit 3 ASTEMIZOLE Calcium Channel Type L, Dihydropyridine 100% 1.617uM 1.04uM View
calcium channel, voltage-dependent, gamma subunit 2 ASTEMIZOLE Calcium Channel Type L, Dihydropyridine 100% 1.617uM 1.04uM View
calcium channel, voltage-dependent, gamma subunit 1 ASTEMIZOLE Calcium Channel Type L, Dihydropyridine 100% 1.617uM 1.04uM View
sodium channel, voltage-gated, type II, beta CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, voltage-gated, type II, alpha 2 CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, voltage-gated, type I, beta CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, voltage-gated, type I, alpha CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
prostaglandin-endoperoxide synthase 1 CLOMIPHENE Cyclooxygenase COX-1 100% .346uM NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) CLOMIPHENE Cyclooxygenase COX-1 100% .346uM NoneNone View
cholinergic receptor, muscarinic 5 ASTEMIZOLE Muscarinic M5 100% .703uM .505uM View
sodium channel, voltage-gated, type IV, beta ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel associated protein 1 ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel associated protein 2 ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, voltage-gated, type III, beta ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, voltage-gated, type I, alpha ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, voltage-gated, type IX, alpha ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, voltage-gated, type VII, alpha ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
amiloride-sensitive cation channel 5, intestinal ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, voltage-gated, type III, beta ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, voltage-gated, type XI, alpha ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, voltage-gated, type I, beta ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, voltage-gated, type 10, alpha polypeptide ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, voltage-gated, type IV, alpha polypeptide ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, voltage-gated, type V, alpha polypeptide ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, voltage-gated, type II, beta ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, nonvoltage-gated 1 alpha ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, nonvoltage-gated 1 gamma ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, nonvoltage-gated 1 beta ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, voltage-gated, type XI, alpha ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, nonvoltage-gated 1, gamma ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, nonvoltage-gated 1, delta ASTEMIZOLE Sodium Channel, Site 2 100% .033uM .03uM View
sodium channel, nonvoltage-gated 1 gamma DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, nonvoltage-gated 1 beta DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, voltage-gated, type XI, alpha DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, nonvoltage-gated 1, gamma DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, nonvoltage-gated 1, delta DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, nonvoltage-gated 1 alpha DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, voltage-gated, type X, alpha DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, voltage-gated, type IX, alpha DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, voltage gated, type VIII, alpha DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, voltage-gated, type VII, alpha DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, voltage-gated, type IV, beta DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, voltage-gated, type IV, alpha DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, voltage-gated, type III, alpha DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, voltage-gated, type II, beta DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, voltage-gated, type II, alpha 2 DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, voltage-gated, type I, beta DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
sodium channel, voltage-gated, type I, alpha DROPERIDOL Sodium Channel, Site 2 100% .271uM .247uM View
adrenergic receptor, alpha 2b HALOPROGIN Adrenergic alpha2B 100% .551uM .251uM View
A3 adenosine receptor HALOPROGIN Adenosine A3 100% .223uM .126uM View
adrenergic receptor, alpha 2a EMETINE Adrenergic alpha2A 100% .038uM .014uM View
dopamine receptor D3 DROPERIDOL Dopamine D3 100% .002765uM .000939uM View
5-hydroxytryptamine (serotonin) receptor 2A DROPERIDOL Serotonin 5-HT2A 100% .002584uM .000738uM View
gamma-aminobutyric acid A receptor, gamma 2 CYCLOSPORIN A GABAA, Agonist Site 23% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit ASTEMIZOLE Calcium Channel Type L, Dihydropyridine 100% 1.617uM 1.04uM View
calcium channel, voltage-dependent, beta 3 subunit ASTEMIZOLE Calcium Channel Type L, Dihydropyridine 100% 1.617uM 1.04uM View
calcium channel, voltage-dependent, beta 2 subunit ASTEMIZOLE Calcium Channel Type L, Dihydropyridine 100% 1.617uM 1.04uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit ASTEMIZOLE Calcium Channel Type L, Dihydropyridine 100% 1.617uM 1.04uM View
calcium channel, voltage-dependent, alpha 1F subunit ASTEMIZOLE Calcium Channel Type L, Dihydropyridine 100% 1.617uM 1.04uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit ASTEMIZOLE Calcium Channel Type L, Dihydropyridine 100% 1.617uM 1.04uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit ASTEMIZOLE Calcium Channel Type L, Dihydropyridine 100% 1.617uM 1.04uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit ASTEMIZOLE Calcium Channel Type L, Dihydropyridine 100% 1.617uM 1.04uM View
calcium channel, voltage-dependent, beta 1 subunit ASTEMIZOLE Calcium Channel Type L, Dihydropyridine 100% 1.617uM 1.04uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit ASTEMIZOLE Calcium Channel Type L, Dihydropyridine 100% 1.617uM 1.04uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit ASTEMIZOLE Calcium Channel Type L, Dihydropyridine 100% 1.617uM 1.04uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 ASTEMIZOLE Calcium Channel Type L, Dihydropyridine 100% 1.617uM 1.04uM View
opioid receptor, kappa 1 NALOXONE Opiate kappa 100% .075uM .03uM View
prostaglandin-endoperoxide synthase 1 PROPOFOL Cyclooxygenase COX-1 100% 3.832uM NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) PROPOFOL Cyclooxygenase COX-1 100% 3.832uM NoneNone View
opioid receptor, delta 1 NALOXONE Opiate delta 100% 1.461uM .515uM View
mu-opioid receptor MOR NALOXONE Opiate mu 100% .02uM .008063uM View
sodium channel, voltage-gated, type IV, beta RALOXIFENE Sodium Channel, Site 2 100% .527uM .48uM View
dopamine receptor D3 CLOMIPHENE Dopamine D3 100% 1.319uM .448uM View
sodium channel, voltage-gated, type IV, beta CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel associated protein 1 CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel associated protein 2 CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, voltage-gated, type III, beta CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, voltage-gated, type I, alpha CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, voltage-gated, type IX, alpha CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, voltage-gated, type VII, alpha CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
amiloride-sensitive cation channel 5, intestinal CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, voltage-gated, type III, beta CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, voltage-gated, type XI, alpha CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, voltage-gated, type I, beta CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, voltage-gated, type 10, alpha polypeptide CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, voltage-gated, type IV, alpha polypeptide CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, voltage-gated, type V, alpha polypeptide CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, voltage-gated, type II, beta CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, nonvoltage-gated 1 alpha CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, nonvoltage-gated 1 gamma CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, nonvoltage-gated 1 beta CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, voltage-gated, type XI, alpha CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, nonvoltage-gated 1, gamma CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, nonvoltage-gated 1, delta CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, nonvoltage-gated 1 alpha CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, voltage-gated, type X, alpha CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, voltage-gated, type IX, alpha CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, voltage gated, type VIII, alpha CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, voltage-gated, type VII, alpha CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, voltage-gated, type IV, beta CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, voltage-gated, type IV, alpha CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, voltage-gated, type III, alpha CLOMIPHENE Sodium Channel, Site 2 100% .636uM .58uM View
sodium channel, voltage-gated, type IX, alpha OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, voltage gated, type VIII, alpha OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, voltage-gated, type VII, alpha OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, voltage-gated, type IV, beta OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, voltage-gated, type IV, alpha OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, voltage-gated, type III, alpha OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, voltage-gated, type II, beta OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, voltage-gated, type II, alpha 2 OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, voltage-gated, type I, beta OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
sodium channel, voltage-gated, type I, alpha OXICONAZOLE Sodium Channel, Site 2 100% 1.473uM 1.3438uM View
dopamine receptor D3 OXICONAZOLE Dopamine D3 100% 1.9937uM .6771uM View
tachykinin receptor 2 OXICONAZOLE Tachykinin NK2 100% 3.2218uM 1.0739uM View
5-hydroxytryptamine (serotonin) receptor 1B OXYMETAZOLINE Serotonin 5-HT1B 100% .002uM .000909uM View
5-hydroxytryptamine (serotonin) receptor 3a ONDANSETRON Serotonin 5-HT3 100% .009292uM .002088uM View
5-hydroxytryptamine (serotonin) receptor 3b ONDANSETRON Serotonin 5-HT3 100% .009292uM .002088uM View
sodium channel, voltage-gated, type IV, beta OXYBUTYNIN Sodium Channel, Site 2 100% 1.1355uM 1.0359uM View
calcium channel, voltage-dependent, gamma subunit 7 EBASTINE Calcium Channel Type L, Benzothiazepine 100% .0653uM .058uM View
calcium channel, voltage-dependent, gamma subunit 6 EBASTINE Calcium Channel Type L, Benzothiazepine 100% .0653uM .058uM View
calcium channel, voltage-dependent, gamma subunit 5 EBASTINE Calcium Channel Type L, Benzothiazepine 100% .0653uM .058uM View
calcium channel, voltage-dependent, gamma subunit 4 EBASTINE Calcium Channel Type L, Benzothiazepine 100% .0653uM .058uM View
calcium channel, voltage-dependent, gamma subunit 3 EBASTINE Calcium Channel Type L, Benzothiazepine 100% .0653uM .058uM View
calcium channel, voltage-dependent, gamma subunit 2 EBASTINE Calcium Channel Type L, Benzothiazepine 100% .0653uM .058uM View
calcium channel, voltage-dependent, gamma subunit 1 EBASTINE Calcium Channel Type L, Benzothiazepine 100% .0653uM .058uM View
calcium channel, voltage-dependent, beta 4 subunit EBASTINE Calcium Channel Type L, Benzothiazepine 100% .0653uM .058uM View
calcium channel, voltage-dependent, beta 3 subunit EBASTINE Calcium Channel Type L, Benzothiazepine 100% .0653uM .058uM View
calcium channel, voltage-dependent, beta 2 subunit EBASTINE Calcium Channel Type L, Benzothiazepine 100% .0653uM .058uM View